Ancora Heart Revenue and Competitors

Location

$151.3M

Total Funding

Estimated Revenue & Valuation

  • Ancora Heart's estimated annual revenue is currently $8.8M per year.(i)
  • Ancora Heart's estimated revenue per employee is $125,500
  • Ancora Heart's total funding is $151.3M.

Employee Data

  • Ancora Heart has 70 Employees.(i)
  • Ancora Heart grew their employee count by 15% last year.

Ancora Heart's People

NameTitleEmail/Phone
1
VP, Regulatory Affairs and Quality AssuranceReveal Email/Phone
2
VP Strategic InitiativesReveal Email/Phone
3
VP Biostatistics and Clinical Data ManagementReveal Email/Phone
4
Chief Commercial OfficerReveal Email/Phone
5
Chief Technical OfficerReveal Email/Phone
6
Sr. Director, Clinical MarketingReveal Email/Phone
7
Manager, Therapy DevelopmentReveal Email/Phone
8
Sr Clinical Marketing ManagerReveal Email/Phone
9
Therapy Development ManagerReveal Email/Phone
10
Manager, Therapy Development Field OperationsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$20.3M817%N/AN/A
#2
$8.5M346%N/AN/A
#3
$4.5M18-10%N/AN/A
#4
$8M32-6%N/AN/A
#5
$5.3M210%N/AN/A
#6
$54.2M2169%N/AN/A
#7
$12M48N/AN/AN/A
#8
$10M405%N/AN/A
#9
$30.1M12022%N/AN/A
#10
$14.1M562%N/AN/A
Add Company

What Is Ancora Heart?

Ancora Heart is a medical device company dedicated to providing new treatment options for people with heart failure (HF). The company’s proprietary AccuCinch® Ventricular Restoration System is the first completely percutaneous device designed to restore the enlarged left ventricle of the heart, thereby addressing the fundamental issue in the progression of systolic heart failure.

keywords:N/A

$151.3M

Total Funding

70

Number of Employees

$8.8M

Revenue (est)

15%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Ancora Heart News

2022-04-06 - Cardiac Restoration Systems Market to Grow by USD 138.68 million ...

Ancora Heart Inc. - The company offers cardiac restoration systems such as AccuCinch Ventricular Restoration System, a transcatheter device...

2018-05-30 - Ancora Heart Raises $17.8M in Funding Round

Ancora Heart, Inc., a Santa Clara, California-based developer of treatments for heart failure, raised $17.8m in a funding round expected to reach $30m. The round was led by Savitr Capital and other existing investors. Led by Jeff Closs, president and CEO, Ancora Heart is advancing AccuCinch® V ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$10.7M7030%N/A
#2
$12.7M710%$36.4M
#3
$17M7151%$28M
#4
$9.3M711%N/A
#5
$9.3M71-3%N/A